Compare Rockwell Automation (ROK) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Rockwell Automation vs GeneDx Holdings Corp — how do they compare? Rockwell Automation trades at $445.51 (market cap $50.13B), while GeneDx Holdings Corp trades at $79 (market cap $2.45B). The key difference: Rockwell Automation is far larger — about 20.5× GeneDx Holdings Corp's market cap, and Rockwell Automation pays a 1.22% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| ROK | WGS | |
|---|---|---|
Market Cap | $50.13B | $2.45B |
Sector | Industrials | Technology |
52-Week High | $495.08 | $167.51 |
52-Week Low | $333.75 | $34.51 |
Enterprise Value | $53.26B | $2.49B |
Dividend Yield | 1.22% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Rockwell Automation (ROK) trades at $445.51, down 0.33% on the day, with a bearish technical signal but strong recent earnings beats. The company reported Q2 2026 EPS of $3.49, exceeding expectations of $3.38, and raised its full-year 2026 outlook. Valuation metrics show a P/E of 42.26 and P/S of 5.66, indicating premium pricing relative to historical norms. Positive news includes AI integration in quality management systems and robust international revenue trends.
Outlook remains cautiously optimistic with a consensus price target of $507, suggesting 14% upside, though high valuation and inflationary pressures pose risks. The stock's investment case hinges on sustained automation demand and margin execution amid broader economic uncertainties.
GeneDx Holdings Corp (WGS) trades at $82.39, up 0.8% today, with a bullish technical signal and strong analyst support. Recent Q2 2026 results beat expectations with $0.01 EPS versus a projected loss, and revenue reached $114.4 million. However, the company shows negative net income margins and high valuation multiples, alongside ongoing class action lawsuits creating headwinds.
The outlook is mixed: robust revenue growth and institutional buying signal potential, but profitability challenges and legal risks warrant caution. With a consensus price target of $79.25 below the current price, near-term pressure may persist despite long-term optimism from 91% buy ratings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Rockwell Automation
Rockwell Automation is a pure-play automation competitor that is the successor entity to Rockwell International, which spun off its former Rockwell Collins avionics segment in 2001. As of fiscal 2021, the firm operates through three segments--intelligent devices, software and control, and lifecycle services. Intelligent devices contains its drives, sensors, and industrial components, software and control contains its information and network and security software, while lifecycle services contains its consulting and maintenance services as well as its Sensia JV with Schlumberger.
Read more on ROK →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
